WENDER PAUL A has a total of 12 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are ACHE LABORATORIOS FARM S A, AQUINOX PHARMACEUTICALS (CANADA) INC and AQUINOX PHARMACEUTICALS CANADA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Medical preparations | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Wender Paul A | 12 |
#2 | Vandeusen Christopher L | 2 |
#3 | Kee Jung-Min | 2 |
#4 | Kreider Erik L | 2 |
#5 | Rothbard Jonathan B | 2 |
#6 | Wright Lee | 2 |
#7 | Pattabiraman Kanaka | 1 |
#8 | Schrier Adam | 1 |
#9 | Jones Lisa R | 1 |
#10 | Warrington Jeffrey | 1 |
Publication | Filing date | Title |
---|---|---|
US2011014699A1 | Prostratin analogs, bryostatin analogs, prodrugs, synthetic methods, and methods of use | |
US2010280262A1 | Bryostatin analogues, synthetic methods and uses | |
US2009270492A1 | Bryostatin analogues, synthetic methods and uses | |
US2009187046A1 | Process to produce prostratin and structural or functional analogs thereof | |
US2008227851A1 | Laulimalide and laulimalide analogs | |
US2006264608A1 | Bi-directional synthesis of oligoguanidine transport agents |